Post obturation analgesia in patients recently vaccinated against Covid-19, after Root canal treatment: a short observational study
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 7, Pages 7737-7745
AbstractAim: The aim of this study was to evaluate the need for analgesia in patients undergoing single-visit root canal treatment, within 2 days after COVID-19 immunisation.
Method: Two days after receiving the COVID-19 vaccination, 50 patients undergoing Single visit root canal treatments for acute pulpits in molar teeth were divided into two groups of 25 each (Group M for males and Group F for females). Each patient was given a prescription for 650 mg of acetaminophen (Dolo 650 mg) tablets to be taken eight hours a day, with instructions to use the same only if needed for pain. They were instructed to keep a record of the number of tablets consumed as per record sheet 1, and if the pain did not subside then a stronger analgesic, Ketorolac DT 10 mg twice a day, had to be taken and recorded.
Results: In Group M, the mean number of analgesic tablets required was 0.44±0.64 and in Group F, the mean number of analgesic tablets required was 0.80±1.09. Although the mean analgesic requirement was higher in females as compared to males, the difference of 0.80±1.09 between the two groups was not significant statistically (0.360).
Conclusion: Within the limitations of this study, it is concluded that acetaminophen is effective in relieving post-obturation pain after a single-visit RCT in patients recently vaccinated against the CoVid-19.
- Article View: 39
- PDF Download: 67